Table of Contents Author Guidelines Submit a Manuscript
Table of Contents Alerts

To receive news and publication updates for Journal of Nanomaterials, enter your email address in the box below.

Journal of Nanomaterials
Volume 2018 (2018), Article ID 6274072, 8 pages
https://doi.org/10.1155/2018/6274072
Research Article

Rapid Adsorption of Proinflammatory Cytokines by Graphene Nanoplatelets and Their Composites for Extracorporeal Detoxification

Yishan Zheng,1 Nicholas Pescatore,2 Yury Gogotsi,2 Boris Dyatkin,2,3 Ganesh Ingavle,1 Vadym Mochalin,4 Tochukwu Ozulumba,1 Sergey Mikhalovsky,1 and Susan Sandeman1

1School of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton BN2 4GJ, UK
2Department of Materials Science & Engineering and A. J. Drexel Nanomaterials Institute, Drexel University, Philadelphia, PA 19104, USA
3Chemistry Division, U.S. Naval Research Laboratory, Washington, DC 20375, USA
4Department of Chemistry and Department of Materials Science & Engineering, Missouri University of Science & Technology, Rolla, MO 65409, USA

Correspondence should be addressed to Susan Sandeman; ku.ca.nothgirb@namednas.s

Received 19 July 2017; Revised 11 January 2018; Accepted 22 January 2018; Published 21 February 2018

Academic Editor: Renyun Zhang

Copyright © 2018 Yishan Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. Y. Dombrovskiy, A. A. Martin, J. Sunderram, and H. L. Paz, “Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003,” Critical Care Medicine, vol. 35, no. 5, pp. 1244–1250, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. A. R. Bedford Russell, “Neonatal sepsis,” Paediatrics and Child Health (United Kingdom), vol. 25, no. 6, pp. 271–275, 2015. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Tiru, E. K. DiNino, A. Orenstein et al., “The economic and humanistic burden of severe sepsis,” PharmacoEconomics, vol. 33, no. 9, pp. 925–937, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. N. K. J. Adhikari, R. A. Fowler, S. Bhagwanjee, and G. D. Rubenfeld, “Critical care and the global burden of critical illness in adults,” The Lancet, vol. 376, no. 9749, pp. 1339–1346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. D. C. Angus and T. van der Poll, “Severe sepsis and septic shock,” The New England Journal of Medicine, vol. 369, no. 9, pp. 840–851, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. K. Baghel, R. N. Srivastava, A. Chandra et al., “TNF-α, IL-6, and IL-8 cytokines and their association with TNF-α-308 G/A polymorphism and postoperative sepsis,” Journal of Gastrointestinal Surgery, vol. 18, no. 8, pp. 1486–1494, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. B. G. Chousterman, F. K. Swirski, and G. F. Weber, “Cytokine storm and sepsis disease pathogenesis,” Seminars in Immunopathology, vol. 39, no. 5, pp. 517–528, 2017. View at Publisher · View at Google Scholar · View at Scopus
  8. A. M. Taeb, M. H. Hooper, and P. E. Marik, “Sepsis: Current definition, pathophysiology, diagnosis, and management,” Nutrition in Clinical Practice, vol. 32, no. 3, pp. 296–308, 2017. View at Publisher · View at Google Scholar · View at Scopus
  9. H. Aoki, M. Kodama, T. Tani, and K. Hanasawa, “Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-inimobilized fiber,” The American Journal of Surgery, vol. 167, no. 4, pp. 412–417, 1994. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Ronco and D. J. Klein, “Polymyxin B hemoperfusion: A mechanistic perspective,” Critical Care, vol. 18, no. 3, article no. 309, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Terayama, K. Yamakawa, Y. Umemura, M. Aihara, and S. Fujimi, “Polymyxin B hemoperfusion for sepsis and septic shock: A systematic review and meta-analysis,” Surgical Infections, vol. 18, no. 3, pp. 225–233, 2017. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Taniguchi, F. Hirai, Y. Takemoto et al., “A novel adsorbent of circulating bacterial toxins and cytokines: The effect of direct hemoperfusion with CTR column for the treatment of experimental endotoxemia,” Critical Care Medicine, vol. 34, no. 3, pp. 800–806, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Kogelmann, D. Jarczak, M. Scheller, and M. Drüner, “Hemoadsorption by CytoSorb in septic patients: a case series,” Critical Care, vol. 21, no. 1, 2017. View at Publisher · View at Google Scholar
  14. S. Inoue, K. Kiriyama, Y. Hatanaka, and H. Kanoh, “Adsorption properties of an activated carbon for 18 cytokines and HMGB1 from inflammatory model plasma,” Colloids and Surfaces B: Biointerfaces, vol. 126, pp. 58–62, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Yachamaneni, G. Yushin, S.-H. Yeon et al., “Mesoporous carbide-derived carbon for cytokine removal from blood plasma,” Biomaterials, vol. 31, no. 18, pp. 4789–4794, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Presser, S. Yeon, C. Vakifahmetoglu et al., “Hierarchical porous carbide-derived carbons for the removal of cytokines from blood plasma,” Advanced Healthcare Materials, vol. 1, no. 6, pp. 682–682, 2012. View at Publisher · View at Google Scholar
  17. S. R. Sandeman, C. A. Howell, S. V. Mikhalovsky et al., “Inflammatory cytokine removal by an activated carbon device in a flowing system,” Biomaterials, vol. 29, no. 11, pp. 1638–1644, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. S. V. Mikhalovsky, “Emerging technologies in extracorporeal treatment: Focus on adsorption,” Perfusion, vol. 18, no. 1, pp. 47–54, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. V. M. Gun'Ko, V. V. Turov, O. P. Kozynchenko et al., “Activation and structural and adsorption features of activated carbons with highly developed micro-, meso- and macroporosity,” Adsorption, vol. 17, no. 3, pp. 453–460, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. X. Li, S. Biswas, and L. T. Drzal, “High temperature vacuum annealing and hydrogenation modification of exfoliated graphite nanoplatelets,” Journal of Engineering (United States), vol. 2013, Article ID 638576, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. L. T. Drzal, Graphene Nanoplatelets: A Muli-Functional Nanomaterial Additive for Polymers and Composites, I. XG Sciences, 2015.
  22. S. Y. Choi, M. Mamak, E. Cordola, and U. Stadler, “Large scale production of high aspect ratio graphite nanoplatelets with tunable oxygen functionality,” Journal of Materials Chemistry, vol. 21, no. 13, pp. 5142–5147, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. A. V. Melezhyk and A. G. Tkachev, “Synthesis of graphene nanoplatelets from peroxosulfate graphite intercalation compounds,” Nanosystems: Physics, Chemistry, Mathematics, vol. 5, no. 2, p. 13, 2014. View at Google Scholar
  24. W. Shen, S. Wen, N. Cao et al., “Expanded graphite - a new kind of biomedical material,” Carbon, vol. 37, no. 2, pp. 356–358, 1999. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Hirn, M. Semmler-Behnke, C. Schleh et al., “Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 77, no. 3, pp. 407–416, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Kurantowicz, B. Strojny, E. Sawosz et al., “Biodistribution of a high dose of diamond, graphite, and graphene oxide nanoparticles after multiple intraperitoneal injections in rats,” Nanoscale Research Letters, vol. 10, no. 1, article no. 398, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Xue, T. Zhang, B. Zhang, F. Gong, Y. Huang, and M. Tang, “Cytotoxicity and apoptosis induced by silver nanoparticles in human liver HepG2 cells in different dispersion media,” Journal of Applied Toxicology, vol. 36, no. 3, pp. 352–360, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. B. K. Gaiser, S. Hirn, A. Kermanizadeh et al., “Effects of silver nanoparticles on the liver and hepatocytes in vitro,” Toxicological Sciences, vol. 131, no. 2, pp. 537–547, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Osswald, J. Chmiola, and Y. Gogotsi, “Structural evolution of carbide-derived carbons upon vacuum annealing,” Carbon, vol. 50, no. 13, pp. 4880–4886, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. B. R. Glick, T. L. Delovitch, and C. L. Patten, “9.1.3 tumor necrosis factor,” in Medical Biotechnology, American Society for Microbiology (ASM).
  31. P. Heering, S. Morgera, F. J. Schmitz et al., “Cytokine removal and cardiovascular hemodynamics in septic patients with continuous venovenous hemofiltration,” Intensive Care Medicine, vol. 23, no. 3, pp. 288–296, 1997. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Harm, F. Gabor, and J. Hartmann, “Characterization of adsorbents for cytokine removal from blood in an in vitro model,” Journal of Immunology Research, vol. 2015, Article ID 484736, 2015. View at Publisher · View at Google Scholar · View at Scopus
  33. G. Yushin, E. N. Hoffman, M. W. Barsoum et al., “Mesoporous carbide-derived carbon with porosity tuned for efficient adsorption of cytokines,” Biomaterials, vol. 27, no. 34, pp. 5755–5762, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. C. A. Howell, S. R. Sandeman, G. J. Phillips et al., “Nanoporous activated carbon beads and monolithic columns as effective hemoadsorbents for inflammatory cytokines,” The International Journal of Artificial Organs, vol. 36, no. 9, pp. 624–632, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. S. R. Tennison et al., “Carbon and its use in blood cleansing applications,” US Pat., 20130072845 A1, 2013.
  36. S. R. Sandeman, Y. Zheng, G. C. Ingavle et al., “A haemocompatible and scalable nanoporous adsorbent monolith synthesised using a novel lignin binder route to augment the adsorption of poorly removed uraemic toxins in haemodialysis,” Biomedical Materials, vol. 12, no. 3, Article ID 035001, 2017. View at Publisher · View at Google Scholar · View at Scopus
  37. S. R. Sandeman, C. A. Howell, G. J. Phillips et al., “An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis,” Journal of Materials Science: Materials in Medicine, vol. 25, no. 6, pp. 1589–1597, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. S. R. Mitzner, J. Stange, S. Klammt, S. Koball, H. Hickstein, and E. C. Reisinger, “Albumin dialysis MARS: Knowledge from 10 years of clinical investigation,” ASAIO Journal, vol. 55, no. 5, pp. 498–502, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Oppert, S. Rademacher, K. Petrasch, and A. Jörres, “Extracorporeal liver support therapy with prometheus in patients with liver failure in the intensive care unit,” Therapeutic Apheresis and Dialysis, vol. 13, no. 5, pp. 426–430, 2009. View at Publisher · View at Google Scholar · View at Scopus